Question 1

Has Danielle Wallace, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $174,292 in general payments to Danielle Wallace, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Danielle Wallace, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Danielle Wallace, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Beone Medicines Ltd.	10	$92,057
Beone Medicines USA, Inc.	2	$39,398
Genentech, Inc.	2	$31,654
Adaptive Biotechnologies Corporation	9	$7,200
Acrotech Biopharma Inc.	5	$3,961
Genmab U.S., Inc.	1	$23

Drug	Claims	Cost to plans & patients
Bexarotene	13	$13,426
Prochlorperazine Maleate	11	$116
Levothyroxine Sodium	13	$61
Prednisone	32	$53
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	13	$16

Danielle Wallace, MD

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Medicare billing

Most prescribed under Part D

Other hematology & oncology in Rochester